Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study

• Egile Nagusiak: Mulugeta Russom (Egilea), Daniel Y. B. Jeannetot (Egilea), Araia Berhane (Egilea), Henok G. Woldu (Egilea), Bruno H. Stricker (Egilea), Katia M. C. Verhamme (Egilea)
• Formatua: Liburua
• Argitaratua: Adis, Springer Healthcare, 2023-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Introduction A 6-month course of isoniazid, 300 mg daily, was programmatically introduced in Eritrea in 2014 as tuberculosis preventive therapy in people living with human immunodeficiency virus (PLHIV). The rollout of isoniazid preventive therapy (IPT) in PLHIV was successful in the first...